Clinical characteristics and predictive model of pulmonary tuberculosis patients with pulmonary fungal coinfection

Table 3 Multivariate analysis of PTB patients with pulmonary fungal coinfection(training dataset, N = 214)

Variable	β-coefficient	S.E	Wald	Sig	Exp(B)	95%CI
Illness course			13.867	0.003
Illness course(1)	1.381	0.518	7.103	0.008	3.978	1.441–10.980
Illness course(2)	1.430	0.667	4.599	0.032	4.180	1.131–15.450
Illness course(3)	2.431	0.691	12.366	< 0.001	11.368	2.933–44.063
Pulmonary cavitation	1.241	0.405	9.377	0.002	3.460	1.563–7.656
Broad-spectrum antibiotics were used for at least 1 week	1.148	0.396	8.425	0.004	3.153	1.452–6.847
Chemotherapy or immunosuppressants	3.028	1.264	5.736	0.017	20.646	1.733–245.934
Surgery	0.769	0.382	4.041	0.044	2.157	1.019–4.565
Bacterial pneumonia	1.894	0.782	5.857	0.016	6.645	1.434–30.799
Hypoproteinemia	1.801	0.593	9.222	0.002	6.054	1.894–19.352

ISSN: 1471-2466